Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
virus
|
| gptkbp:barrelLength |
high in horses
low in humans |
| gptkbp:causedBy |
gptkb:Venezuelan_equine_encephalitis
|
| gptkbp:community |
education on prevention
vector control measures surveillance required |
| gptkbp:conflict |
gptkb:Eastern_equine_encephalitis_virus
Western equine encephalitis virus |
| gptkbp:diseaseResistance |
serological tests
endemic in certain regions PCR tests epidemic potential zoonotic disease reported in horses reported in humans |
| gptkbp:family |
Togaviridae
|
| gptkbp:first_held |
1930s
|
| gptkbp:geneticDiversity |
single-stranded RNA
positive-sense RNA |
| gptkbp:genus |
gptkb:Alphavirus
|
| gptkbp:geographicalFeature |
Americas
|
| https://www.w3.org/2000/01/rdf-schema#label |
VEEV
|
| gptkbp:impact |
supportive care
no specific antiviral treatment |
| gptkbp:incubationPeriod |
2 to 6 days
|
| gptkbp:notable_player |
live attenuated vaccine
safety profile established efficacy studies ongoing immunization recommended for at-risk populations not widely used in humans used in horses |
| gptkbp:portrayedBy |
occurs in cytoplasm
involves host cell machinery |
| gptkbp:propulsion |
Aedes mosquitoes
Culex mosquitoes |
| gptkbp:research |
vaccine development
epidemiology studies pathogenesis studies |
| gptkbp:reservoir |
horses
|
| gptkbp:safetyFeatures |
vaccination
mosquito_control |
| gptkbp:symptoms |
headache
muscle pain fever confusion seizures rash coma neurological complications |
| gptkbp:transmission |
vertical transmission
blood transfusion mosquito bites |